OA12348A - Particulate composition of eletriptan showing a sigmoidal pattern of controlled release. - Google Patents

Particulate composition of eletriptan showing a sigmoidal pattern of controlled release. Download PDF

Info

Publication number
OA12348A
OA12348A OA1200300020A OA1200300020A OA12348A OA 12348 A OA12348 A OA 12348A OA 1200300020 A OA1200300020 A OA 1200300020A OA 1200300020 A OA1200300020 A OA 1200300020A OA 12348 A OA12348 A OA 12348A
Authority
OA
OAPI
Prior art keywords
composition
eletriptan
drug
core
daims
Prior art date
Application number
OA1200300020A
Other languages
English (en)
Inventor
Manaud Pierre Frederic Raspide
Ross James Macrae
Mathias Walther
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of OA12348A publication Critical patent/OA12348A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electroluminescent Light Sources (AREA)
  • Luminescent Compositions (AREA)
OA1200300020A 2000-08-02 2001-07-18 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release. OA12348A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0018968.8A GB0018968D0 (en) 2000-08-02 2000-08-02 Particulate composition

Publications (1)

Publication Number Publication Date
OA12348A true OA12348A (en) 2004-03-19

Family

ID=9896843

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200300020A OA12348A (en) 2000-08-02 2001-07-18 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release.

Country Status (39)

Country Link
US (1) US20020034545A1 (pl)
EP (1) EP1365748B1 (pl)
JP (1) JP2004505034A (pl)
KR (1) KR20030024820A (pl)
CN (1) CN1630511A (pl)
AP (1) AP2001002233A0 (pl)
AR (1) AR030099A1 (pl)
AT (1) ATE308978T1 (pl)
AU (1) AU2001270932A1 (pl)
BG (1) BG107361A (pl)
BR (1) BR0112839A (pl)
CA (1) CA2417887C (pl)
CZ (1) CZ2003241A3 (pl)
DE (1) DE60114887T2 (pl)
EA (1) EA200300110A1 (pl)
EC (1) ECSP034451A (pl)
EE (1) EE200300051A (pl)
ES (1) ES2250429T3 (pl)
GB (1) GB0018968D0 (pl)
GT (1) GT200100149A (pl)
HR (1) HRP20030036A2 (pl)
HU (1) HUP0301453A2 (pl)
IL (1) IL153494A0 (pl)
IS (1) IS6649A (pl)
MA (1) MA26934A1 (pl)
MX (1) MXPA03000999A (pl)
NO (1) NO20030498D0 (pl)
NZ (1) NZ522976A (pl)
OA (1) OA12348A (pl)
PA (1) PA8523101A1 (pl)
PE (1) PE20020385A1 (pl)
PL (1) PL359847A1 (pl)
PY (1) PY0117547A (pl)
SK (1) SK1082003A3 (pl)
SV (1) SV2002000574A (pl)
TN (1) TNSN01115A1 (pl)
UY (1) UY26861A1 (pl)
WO (1) WO2002009675A1 (pl)
ZA (1) ZA200300868B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022853A1 (en) * 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
AU2003294520A1 (en) * 2002-12-16 2004-07-09 Chx Technologies, Inc. Temporary, pharmacologically-inactive dental coating for the in situ protection of dental therapeutic agents from saliva and abrasion from chewing
WO2004089365A1 (en) 2003-04-11 2004-10-21 Pfizer Limited Pharmaceutical combination comprising eletriptan and sodium bicarbonate
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
WO2005120456A2 (en) * 2004-06-09 2005-12-22 Pfizer Limited Formulation of eletriptan
WO2006013431A1 (en) * 2004-07-29 2006-02-09 Pfizer Limited Stable controlled-release pharmaceutical formulation of eletriptan
WO2006080481A1 (ja) * 2005-01-31 2006-08-03 Kyorin Pharmaceutical Co., Ltd. マルチプルユニット型経口徐放性製剤及びその製造方法
US11311490B2 (en) 2005-08-10 2022-04-26 Add Advanced Drug Delivery Technologies Ltd. Oral preparation with controlled release
US20070134322A1 (en) * 2005-12-14 2007-06-14 Forest Laboratories, Inc. Modified and pulsatile release pharmaceutical formulations of escitalopram
ES2396051T3 (es) * 2006-04-26 2013-02-18 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal
WO2008115797A1 (en) * 2007-03-16 2008-09-25 Pavo, Inc. Therapeutic compositions and methods
CA2694440A1 (en) 2007-07-25 2009-01-29 Biolex Therapeutics, Inc. Controlled release interferon drug products and treatment of hcv infection using same
KR20120110098A (ko) 2009-11-16 2012-10-09 에보니크 룀 게엠베하 고형 (메트)아크릴레이트 공중합체를 분산제에 의해 분산된 형태로 전환시키는 방법
BR112017004552A2 (pt) * 2014-09-09 2017-12-05 Charleston Laboratories Inc composições farmacêuticas
GB201716716D0 (en) * 2017-10-12 2017-11-29 Univ Of Hertfordshire Higher Education Corporation Method for coating particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9922963D0 (en) * 1999-09-28 1999-12-01 Pfizer Ltd Polymorphic salt
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release

Also Published As

Publication number Publication date
TNSN01115A1 (fr) 2005-11-10
EP1365748B1 (en) 2005-11-09
GT200100149A (es) 2002-06-25
KR20030024820A (ko) 2003-03-26
NO20030498L (no) 2003-01-31
DE60114887D1 (de) 2005-12-15
PY0117547A (es) 2003-11-03
PA8523101A1 (es) 2002-08-26
DE60114887T2 (de) 2006-07-20
SV2002000574A (es) 2002-12-02
HUP0301453A2 (hu) 2003-08-28
AP2001002233A0 (en) 2001-09-30
BG107361A (bg) 2003-06-30
EE200300051A (et) 2004-10-15
NZ522976A (en) 2004-11-26
ECSP034451A (es) 2003-03-10
ES2250429T3 (es) 2006-04-16
ZA200300868B (en) 2004-04-16
MXPA03000999A (es) 2003-06-09
HRP20030036A2 (en) 2003-04-30
CA2417887A1 (en) 2002-02-07
BR0112839A (pt) 2003-06-24
CN1630511A (zh) 2005-06-22
AU2001270932A1 (en) 2002-02-13
CA2417887C (en) 2006-11-14
WO2002009675A9 (en) 2003-09-18
WO2002009675A1 (en) 2002-02-07
UY26861A1 (es) 2002-02-28
IL153494A0 (en) 2003-07-06
JP2004505034A (ja) 2004-02-19
AR030099A1 (es) 2003-08-13
PE20020385A1 (es) 2002-05-11
IS6649A (is) 2002-12-05
GB0018968D0 (en) 2000-09-20
EP1365748A2 (en) 2003-12-03
SK1082003A3 (en) 2004-09-08
ATE308978T1 (de) 2005-11-15
EA200300110A1 (ru) 2003-06-26
NO20030498D0 (no) 2003-01-31
CZ2003241A3 (cs) 2004-02-18
MA26934A1 (fr) 2004-12-20
PL359847A1 (pl) 2004-09-06
US20020034545A1 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
CN103211779B (zh) 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统
JP2002532425A (ja) 新規な医薬製剤
EP1365748B1 (en) Particulate composition of eletriptan hydrobromide showing a sigmoidal pattern of controlled release
JPH11501948A (ja) プロトンポンプ阻害剤およびｎｓａｉｄからなる経口用医薬剤形
TWI483748B (zh) 含有氫嗎啡酮（ｈｙｄｒｏｍｏｒｐｈｏｎｅ）和納洛酮（ｎａｌｏｘｏｎｅ）之藥學組成物
JP2002523443A (ja) オメプラゾール製剤
ITMI970016A1 (it) Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
CZ2000344A3 (cs) Orální farmaceutický postředek obsahující sloučeninu s protivředovou aktivitou a způsob jeho přípravy
US20090004284A1 (en) Controlled release tamsulosin hydrochloride formulation
HUP9904401A2 (hu) [R-(Z)]-alfa-(Metoxi-imino)-alfa-(1-aza-biciklo[2.2.2]okt-3-il)-acetonitril-monohidroklorid hatóanyag-tartalmú szabályozott kibocsátású dózisforma
CA2967647A1 (en) Pharmaceutical bead formulations comprising dimethyl fumarate
EP1633330A2 (en) Extended release osmo-microsealed formulation
KR20110102339A (ko) 고정용량 복합제용 탐술로신 펠렛
EP1781275B1 (en) Sustained release pharmaceutical composition of tolterodine
US20090192228A1 (en) Controlled-Release Tolterodine Compositions and Methods
WO2006049564A1 (en) New modified release pellet formulations for proton pump inhibitors
CN101208078A (zh) 基于质子泵抑制剂的口服药剂
ZA200410333B (en) Microcapsules for the delayed, controlled release of perindropil
EP1912631A2 (en) Diltiazem controlled release formulation and method of manufacture
CN101132782A (zh) 氯沙坦的口服药物剂型
JPWO2001076635A1 (ja) 胆汁酸性下痢の防止用製剤